Neither Covaxin nor Covishield are made from the vaccine. More antibodies, shocking claim by ICMR president

New delhi date. May 21, 2021, Friday

Vaccines are seen as a great weapon against the Corona epidemic. In India, the government has started vaccinating people over the age of 18. There are currently two vaccines available in the country. Covishield of Bharat Biotech Co Vaccine and Serum Institute of India. Meanwhile the most talked about topic among the people is which of the two is the most effective vaccine.

Dr. Balram Bhargava, DG, Indian Council of Medical Research (ICMR) has made an important statement regarding this opinion. ICMR President Dr. Balram Bhargava has made a shocking claim about taking antibodies produced by covexin and cove shield. "After taking the first dose of Covishield, more antibodies are produced compared to the first dose of Covexina," he said.

According to a report, Dr. Balram Bhargava said, "A new study has found that antibodies are not formed after the first dose of covexin, but enough antibodies are obtained after the second dose. It is only after taking the first dose of Covishield that a good number of antibodies are formed.

The time between the two doses of Covishield has been increased to 12-18 weeks. Antibodies are more common after the first dose. On the other hand there was no change in the distance between the two doses of covexin. Commenting on the government's decision to make Covishield's 3-month period mandatory, Balram Bhargava said, "Immunity has increased a lot after the first dose and three months will give good results."